The effect of newer antipsychotics on negative symptoms

被引：0

作者：

Gaebel, W ^{[1
]}

机构：

[1] Univ Dusseldorf, Dept Psychiat, D-4000 Dusseldorf, Germany

来源：

NORDIC JOURNAL OF PSYCHIATRY | 2000年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：22 / 22

页数：1

共 50 条

[31] Newer antipsychotics no safer than older agents?
[J]. Reactions Weekly, 2009, 1236 (1) : 4 - 4
[32] Chlorpromazine equivalent doses for the newer atypical antipsychotics
Woods, SW
[J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (06) : 663 - 667
[33] Cardiotoxicity of newer antipsychotics: Mechanisms, diagnosis and management
Thomas, Simon H. L.
[J]. CLINICAL TOXICOLOGY, 2013, 51 (04) : 299 - 300
[34] Treatment with six different antipsychotics: Evaluation by scale for the assessment of negative symptoms (SANS)
Uzun, S
Kozumplik, O
Mimica, N
Folnegovic-Smalc, V
[J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 98 - 99
[35] Review: Adding SSRIs to antipsychotics does not improve negative symptoms in people with schizophrenia
Lecrubier, Yves
[J]. EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (04)
[36] Results and methodological problems in the evaluation of newer atypical neuroleptics in the treatment of schizophrenic negative symptoms
Möller, HJ
[J]. NERVENARZT, 2000, 71 (05): : 345 - 353
[37] Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved
Koga, M
Nakayama, K
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (01) : 75 - 76
[38] Lisdexamfetamine Dimesylate as Adjunctive Treatment with Antipsychotics for Predominant Negative Symptoms of Schizophrenia: Concurrent Neurocognitive and Negative Symptom Improvement
Nasrallah, Henry A.
Keefe, Richard
Lasser, Robert
Dirks, Bryan
Kirsch, Courtney
Wang, Jiannong
Scheckner, Brian
Lindenmayer, Jean-Pierre
[J]. BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 65S - 65S
[39] Comparisons of the effects of the newer atypical antipsychotics in the treatment of schizophrenia
Davis, JW
Glick, ID
[J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 276 - 276
[40] Behavioural problems associated with dementia - The role of newer antipsychotics
Stoppe, G
Brandt, CA
Staedt, JH
[J]. DRUGS & AGING, 1999, 14 (01) : 41 - 54

← 1 2 3 4 5 →